Legal https://www.benzinga.com/views/taxonomy/term/29619 en Bragar Eagel & Squire, P.C. Is Investigating HEXO, Pareteum, Qiagen, and Zendesk on Behalf of Stockholders and Encourages Investors to Contact the Firm https://www.benzinga.com/pressreleases/19/10/g14641491/bragar-eagel-squire-p-c-is-investigating-hexo-pareteum-qiagen-and-zendesk-on-behalf-of-stockholder <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel &amp; Squire, P.C., a nationally recognized shareholder law firm, is investigating potential claims against HEXO Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HEXO#NYSE" rel="nofollow">HEXO</a>), Pareteum Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEUM#NASDAQ" rel="nofollow">TEUM</a>), Qiagen N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QGEN#NYSE" rel="nofollow">QGEN</a>), and Zendesk, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZEN#NYSE" rel="nofollow">ZEN</a>) on behalf of investors. Our investigation concerns whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.<br /></p> <p align="justify"><strong>HEXO Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HEXO#NYSE" rel="nofollow">HEXO</a>)</strong></p> <p align="justify">On October 4, 2019, HEXO announced the immediate resignation of its Chief Financial Officer Michael Monahan, after only four months as the Company&#039;s CFO.</p> <p align="justify">On this news, HEXO&#039;s stock price fell $0.26 per share, or 6.4%, to close at $3.80 per share on October 7, 2019.</p> <p align="justify">Then, on October 10, 2019, HEXO released preliminary revenue results for the fourth quarter of fiscal year 2019 that were nearly 50% lower than previous guidance and withdrew previously announced fiscal year 2020 guidance of up to $400 million in revenue. HEXO&#039;s Chief Executive Officer Sebastien St-Louis attributed these poor results to "lower than expected product sell through" and admitted that the company would have to make "significant changes to our sales and operations strategy to drive future results."</p> <p align="justify">On this news, HEXO&#039;s stock price ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14641491/bragar-eagel-squire-p-c-is-investigating-hexo-pareteum-qiagen-and-zendesk-on-behalf-of-stockholder alt=Bragar Eagel &amp; Squire, P.C. Is Investigating HEXO, Pareteum, Qiagen, and Zendesk on Behalf of Stockholders and Encourages Investors to Contact the Firm>Full story available on Benzinga.com</a></p> HEXO News QGEN TEUM ZEN Legal Press Releases QGEN NL0000240000 ZEN TEUM HEXO News Legal Press Releases Benzinga Wed, 23 Oct 2019 00:35:52 +0000 Globe Newswire 14641491 at https://www.benzinga.com HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, REMIND VIEWRAY (VRAY) INVESTORS OF SECURITIES CLASS ACTION: Firm Encourages Investors Who Have Suffered Losses to Contact the Firm Now https://www.benzinga.com/pressreleases/19/10/g14641490/hagens-berman-national-trial-attorneys-remind-viewray-vray-investors-of-securities-class-action-fi <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="left"><strong><em>Class-action law firm urges VRAY investors who have suffered losses of 50K+ to <a href="https://www.globenewswire.com/Tracker?data=Wa7GAJkjpG9-jYhSyner5Mqx5h-MG4UYbqUrxiSylZDIDGd02SRkq3QckLv-F28pV3XOqhgprv3b1ueTJRKVliwI9pYMQ0_kuUO-HnvzhiymRaR2l-eIFzDv7X_QyvU9" rel="nofollow" target="_blank" rel="nofollow"><u>submit your loss now</u></a> to learn if they qualify to recover their investment losses.</em></strong><br /></p> <p>SAN FRANCISCO, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in ViewRay, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAY#NASDAQ" rel="nofollow">VRAY</a>) of the pending securities fraud class action and urges VRAY investors who have suffered losses in excess of $50,000 to contact the firm.</p> <p><strong>Class Period:</strong> Mar. 15, 2019 – Aug. 8, 2019<strong><br /> Lead Plaintiff Deadline:</strong> Nov. 12, 2019<strong><br /> Sign Up</strong>: <a href="https://www.globenewswire.com/Tracker?data=lqFfbM_GiPnljSiX8AlNNpUMc98ADWQbOCByGQjPDsQbF_plZAsKrk1vck7O-HRD2BpcgGn3V6_8ngoeCt08ZwRDhJCggBqLjpo5Y5q3dX5_fk-mK15GvF34I6qdNynxe8k8p4ho18eEKPe7xh3SxA==" rel="nofollow" target="_blank" rel="nofollow"><u>www.hbsslaw.com/investor-fraud/VRAY</u></a> <br /><strong>Contact An Attorney Now</strong>: <a href="https://www.globenewswire.com/Tracker?data=TBaMc121uO9DrP8Lje6fUUOAVL7sdChhgkPFeGu7VNC8MhDD__FQxpGbl4GiIUr2bvbu5p-auyT6Culgdqeidw==" rel="nofollow" target="_blank" rel="nofollow"><u>VRAY@hbsslaw.com</u></a><br /><strong>510-725-3000</strong></p> <p><strong>VRAY Securities Class Action:</strong></p> <p><strong>According to the ...</strong></p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14641490/hagens-berman-national-trial-attorneys-remind-viewray-vray-investors-of-securities-class-action-fi alt=HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, REMIND VIEWRAY (VRAY) INVESTORS OF SECURITIES CLASS ACTION: Firm Encourages Investors Who Have Suffered Losses to Contact the Firm Now>Full story available on Benzinga.com</a></p> News VRAY Legal Press Releases VRAY News Legal Press Releases Benzinga Wed, 23 Oct 2019 00:35:05 +0000 Globe Newswire 14641490 at https://www.benzinga.com HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, REMIND MACROGENICS (MGNX) INVESTORS OF SECURITIES CLASS ACTION: Firm Encourages Investors Who Have Suffered Losses to Contact the Firm Now https://www.benzinga.com/pressreleases/19/10/g14641362/hagens-berman-national-trial-attorneys-remind-macrogenics-mgnx-investors-of-securities-class-actio <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="left"><strong><em>Class-action law firm urges MGNX investors who have suffered losses of</em></strong><strong><em> $50K+ </em></strong><strong><em>to <a href="https://www.globenewswire.com/Tracker?data=JsFq8170ACGXGgGEa1ahbJwwyIHuyEP9JFgjotjokL4bpoWjhr3AF4VHvKaz3krSKZG8MydxE2cXM-t_bT2gnel9I3EmufPsPoPm0FeKP8hf61-bUCV9KEQy-cXzwu3t" rel="nofollow" target="_blank" rel="nofollow"><u>submit your loss now</u></a> to learn if they qualify to recover their investment losses.</em></strong><br /></p> <p>SAN FRANCISCO, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in MacroGenics (MGNX) of the securities fraud class action filed against the company and urges MGNX investors who have suffered losses in excess of $50,000 to contact the firm.</p> <p><strong>Class Period:</strong> Feb. 6, 2019 – June 3, 2019<strong><br /> Lead Plaintiff Deadline:</strong> Nov. 12, 2019<strong><br /> Sign Up</strong>:   <a href="https://www.globenewswire.com/Tracker?data=wDtNQBjNRyscDDI8NGS7bi_1anQ5zFPXvnNlqexbCfHkljICdFkdfICHLt0w8ey7-JprcnAWTd-xcP2uMkWpChEfO70giLwjnuM_WkFyZZRv8D58x-Yjonxn9eY4MsMu25BtFW0SjgNj4dQqnjVCfg==" rel="nofollow" target="_blank" rel="nofollow"><u>https://www.hbsslaw.com/investor-fraud/mgnx</u></a><br /><strong>Contact An Attorney Now</strong>: <a href="https://www.globenewswire.com/Tracker?data=11z2HjQK08MIzVK_qJByODdFo229sUM6ELLghAiuFdhOnUMEJbiBfc4sP4rI3Iza7kYX1orS9jANzbP2-nNpZQ==" rel="nofollow" target="_blank" rel="nofollow"><u>MGNX@hbsslaw.com</u></a> <br /><strong>                                           510-725-3000</strong></p> <p><strong>MGNX</strong><strong> Securities Class Action:</strong></p> <p><strong>According to the Complaint, Defendants concealed adverse information obtained during MacroGenics&#039; ...</strong></p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14641362/hagens-berman-national-trial-attorneys-remind-macrogenics-mgnx-investors-of-securities-class-actio alt=HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, REMIND MACROGENICS (MGNX) INVESTORS OF SECURITIES CLASS ACTION: Firm Encourages Investors Who Have Suffered Losses to Contact the Firm Now>Full story available on Benzinga.com</a></p> News Legal Press Releases News Legal Press Releases Benzinga Wed, 23 Oct 2019 00:00:42 +0000 Globe Newswire 14641362 at https://www.benzinga.com HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, UPDATE COVETRUS (CVET) INVESTORS OF CEO RESIGNATION: Notifies Investors of Securities Fraud Lawsuit and Application Process https://www.benzinga.com/pressreleases/19/10/g14640460/hagens-berman-national-trial-attorneys-update-covetrus-cvet-investors-of-ceo-resignation-notifies- <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="left"><strong><em>Class-action law firm urges CVET investors who have suffered losses of 50K+ to <a href="https://www.globenewswire.com/Tracker?data=ntBqWvO66VxHXgOH10aGLud1NlDYPi8ITt3McNnkE3hGKA9I3DX3kc4ykZ7a5eT1UQe7Dnt8TfdO33Ood0ztTrAyakzOhdX87JRmi4I9Bag3ezwQagoqY1Ym8Iq9FikG" rel="nofollow" target="_blank" rel="nofollow"><u>submit your loss now</u></a> to learn if they qualify to recover their investment losses.</em></strong><br /></p> <p>SAN FRANCISCO, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Covetrus, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVET#NASDAQ" rel="nofollow">CVET</a>) of the pending securities fraud class action and urges CVET investors who have suffered losses in excess of $50,000 to contact the firm.</p> <p><strong>Class Period: </strong>Feb. 8, 2019 – Aug. 12, 2019<br /><strong>Lead Plaintiff Deadline: </strong>Nov. 29, 2019<br /><strong>Sign Up: </strong><a href="https://www.globenewswire.com/Tracker?data=hx5KlUsIYAecT9lKPxHxg3LK1NMK9U7nFUUSrFfum7VXT9JaQMsocEnukm38zoEXO5TCMvr0QwGAbxMZg9455mzizerCWeagu5kV7VF_qr29LRKVZXWtfGy9yCFk5XtqQnhryG29I40X52LYoILkpw==" rel="nofollow" target="_blank" rel="nofollow"><u>www.hbsslaw.com/investor-fraud/CVET</u></a> <br /><strong>Contact An Attorney Now: </strong><a href="https://www.globenewswire.com/Tracker?data=8y74NM9w0dL8Nik8eK260OTb4EhvlsJP_mmJcgeUheeKCYeulldQT59xdh3V4ofJSHsCRU8rgrEO7b-gUFkeWw==" rel="nofollow" target="_blank" rel="nofollow"><u>CVET@hbsslaw.com</u></a> <br />                                          <strong>(510) 725-3000</strong></p> <p><strong>CVET Securities Class Action:</strong></p> <p><strong>According to the Complaint, </strong>Defendants misled investors about the ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14640460/hagens-berman-national-trial-attorneys-update-covetrus-cvet-investors-of-ceo-resignation-notifies- alt=HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, UPDATE COVETRUS (CVET) INVESTORS OF CEO RESIGNATION: Notifies Investors of Securities Fraud Lawsuit and Application Process>Full story available on Benzinga.com</a></p> CVET News Legal Press Releases CVET News Legal Press Releases Benzinga Tue, 22 Oct 2019 20:40:12 +0000 Globe Newswire 14640460 at https://www.benzinga.com Ex-Dallas Police Officer Pleads Guilty To Fraudulent Ticket-Writing Scheme To Collect Federal Grant Money https://www.benzinga.com/news/19/10/14639545/ex-dallas-police-officer-pleads-guilty-to-fraudulent-ticket-writing-scheme-to-collect-federal-grant <p>A former Dallas police officer pleaded guilty on October 16 to falsifying traffic tickets in order to collect overtime pay through a program funded by a federal grant aimed at curbing fatal and serious injury crashes on Dallas roadways.</p> <p>Matthew Alan Rushing, 35, pleaded guilty to one count of making a false statement in U.S. District Court in Dallas. He worked as a Dallas police officer for more than 11 years before his arrest in late June 2019.</p> <p>According to his plea agreement, Rushing admitted to submitting at least 38 fraudulent "Officer&#039;s Daily Grant Activity Reports, which included citations for fictitious persons and ...</p><p><a href=https://www.benzinga.com/news/19/10/14639545/ex-dallas-police-officer-pleads-guilty-to-fraudulent-ticket-writing-scheme-to-collect-federal-grant alt=Ex-Dallas Police Officer Pleads Guilty To Fraudulent Ticket-Writing Scheme To Collect Federal Grant Money>Full story available on Benzinga.com</a></p> Freight Freightwaves lawsuit News Legal General News Legal General Benzinga Tue, 22 Oct 2019 20:24:02 +0000 FreightWaves 14639545 at https://www.benzinga.com SLACK TECHNOLOGIES, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District for the Northern District of California against Slack Technologies, Inc. https://www.benzinga.com/pressreleases/19/10/g14640100/slack-technologies-inc-investor-alert-wolf-haldenstein-adler-freeman-herz-llp-announces-that-a-sec <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="justify">NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=aVqyyRSqoQ8B8KAXRNPy5MF2n-9By5HnlZGbP03QZG2nxy1j0rPneyd3hAIzwUtnj2iiFM-NKGpShbdRA4tEFC_2eeo3pWDzygASz1q0xx-m5lC9he4A6mgyzNVMjkLXdUIXviVwuMD0nkgT9GMZIBM8vJqNq3vYc08tJAFsy88=" rel="nofollow" target="_blank" rel="nofollow"><u>Wolf Haldenstein Adler Freeman &amp; Herz LLP</u></a> announces that a federal securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of persons and entities that purchased or otherwise acquired Slack Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WORK#NYSE" rel="nofollow">WORK</a>) ("Slack" or the "Company") Class A common stock pursuant and/or traceable to the Company&#039;s registration statement and prospectus (collectively, the "Registration Statement") on or around June 20, 2019 (the "Offering").</p> <p align="justify"><strong>Investors who purchased shares </strong><strong>of Slack Technologies, Inc. are urged</strong><strong> to contact the firm immediately at <a href="https://www.globenewswire.com/Tracker?data=DNRTjmTR148RAq-5edHbbpgnpNw3-_UuuFyCnuOtF8VczXgOmULVuM3R6X9G-dpKGcY1aAO4_KDgXX0Fxb74VKR9u0VBXRiODwd-RS2_hs0=" rel="nofollow" target="_blank" rel="nofollow"><u>classmember@whafh.com</u></a> or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action on our website, <a href="https://www.globenewswire.com/Tracker?data=e4h-DsfEpLTlZbR6-S2LwcUjimHW_wVdIJ7Lwp6HD8HxXmILaP3006jjzcImY9xLEouFySO3bpHqXOkl0JzR4XqbvOrlnF_X59SsZQEmMm-X_zW-6hKNiWevhYPphtCw" rel="nofollow" target="_blank" rel="nofollow">www.whafh.com.</a></strong></p> <p align="justify">If you have incurred losses in the shares of <strong>Slack Technologies, Inc.</strong>, <strong>you</strong> <strong>may,</strong> <strong>no later than November 18, 2019</strong><strong>, </strong>request that the Court appoint you lead plaintiff of the proposed class. Please contact <a href="https://www.globenewswire.com/Tracker?data=aVqyyRSqoQ8B8KAXRNPy5CzW59n1wrk5GrE0Q8M8Qy__k2vTV4ti7vdrP0OlQN0WCKdasOMOFhTfDR8XKcTP4Q==" rel="nofollow" target="_blank" rel="nofollow"><u>Wolf Haldenstein</u></a> to learn more about your rights as an investor in the shares of <strong>Slack Technologies, Inc.</strong></p> <p align="center">## Follow the firm and learn ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14640100/slack-technologies-inc-investor-alert-wolf-haldenstein-adler-freeman-herz-llp-announces-that-a-sec alt=SLACK TECHNOLOGIES, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a securities class action lawsuit has been filed in the United States District for the Northern District of California against Slack Technologies, Inc.>Full story available on Benzinga.com</a></p> News WORK Legal Press Releases WORK News Legal Press Releases Benzinga Tue, 22 Oct 2019 20:15:05 +0000 Globe Newswire 14640100 at https://www.benzinga.com RUHNN HOLDING LIMITED INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District for the Eastern District of New York https://www.benzinga.com/pressreleases/19/10/g14640098/ruhnn-holding-limited-investor-alert-wolf-haldenstein-adler-freeman-herz-llp-announces-that-a-secu <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="center"><strong><strong>LEAD PLAINTIFF DEADLINE IS</strong></strong><strong><strong> DECEMBER 6, 2019</strong></strong></p> <p align="justify">NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=PClSQQHAXXMn8i5Rk_696yofm0z4NUICt1oOXNJiY8h8clXHOCausOL2TyzEczfKRBYhDDyEAp0mivT1qVuoaqBVIiVsb4JSujWl6S4bdCJGKtsWryyrlgRWEQtxIyv9bNeRz2ZNc8NjatvwdyqxQA551nfHKBOZF09skg-tq4FOrLtgsinnYGEcmd6P0pEJhXkWinrHdTS6MgWuQ08tng==" rel="nofollow" target="_blank" rel="nofollow"><u>Wolf Haldenstein Adler Freeman &amp; Herz LLP</u></a> announces that a class action lawsuit has been filed in the United States District for the Eastern District of New York on behalf of investors that purchased Ruhnn Holding Limited ("Ruhnn" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUHN#NASDAQ" rel="nofollow">RUHN</a>) American Depositary Shares ("ADS&#039;s") pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with Ruhnn&#039;s April 2019 initial public offering (the "IPO" or the "Offering").</p> <p align="justify"><strong>Investors who purchased shares </strong><strong>of Ruhnn Holding Limited are urged</strong><strong> to contact the firm immediately at <a href="https://www.globenewswire.com/Tracker?data=Mfx2MKthrfxW4fpgwKwCODJTxU21iqv3cASbnmrpdtRZaD0YIS2Rjpufw4B63jL0p5i-JhBspOP5Ei7R-saciQ0djQimj_ltKTILIKWMQDE=" rel="nofollow" target="_blank" rel="nofollow"><u>classmember@whafh.com</u></a> or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action on our website, <a href="https://www.globenewswire.com/Tracker?data=q7tQcp7c0gqmx0msiAaMg10asIaMlpoMHiCFMQ5uZRw5HH5o_kEMk5unwowC8ZCkzkuqBHPf1C4pTWqFYR-5WSOBOfISa40YYjAk3Jj7AJiB-ATVV10Mw8ErKcr-g0WoiS45YEkwYP0NUXEuqYDDUHgP9kWnt7OCL_kelHr9pic=" rel="nofollow" target="_blank" rel="nofollow">www.whafh.com.</a></strong></p> <p align="justify">If you have incurred losses in the shares of Ruhnn Holding Limited,<strong> y</strong><strong>ou may,</strong> <strong>no later than December 6, 2019</strong><strong>, </strong>request that the Court appoint you lead plaintiff of the proposed class. Please contact <a href="https://www.globenewswire.com/Tracker?data=PClSQQHAXXMn8i5Rk_6968yFCv7BBQ4uxaxx-TqrbdPkfzaUqTGBMEeGHxJYRlHGSFvJ4R7T7cgCXID7i4DCtQ==" rel="nofollow" target="_blank" rel="nofollow"><u>Wolf Haldenstein</u></a> to learn more about your rights as an investor in ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14640098/ruhnn-holding-limited-investor-alert-wolf-haldenstein-adler-freeman-herz-llp-announces-that-a-secu alt=RUHNN HOLDING LIMITED INVESTOR ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a securities class action lawsuit has been filed in the United States District for the Eastern District of New York>Full story available on Benzinga.com</a></p> News RUHN Legal Press Releases RUHN News Legal Press Releases Benzinga Tue, 22 Oct 2019 20:15:05 +0000 Globe Newswire 14640098 at https://www.benzinga.com MATCH GROUP, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District for the Northern District of Texas on behalf of purchasers of the securities of Match Group, Inc. https://www.benzinga.com/pressreleases/19/10/g14640093/match-group-inc-investor-alert-wolf-haldenstein-adler-freeman-herz-llp-announces-that-a-securities <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="justify">NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=WDLpZgPRVudr8C2jUHjiIywkCBQAwBCYTdb6PsUiEYsedYl2NwmBdA5geX7zYeX7aFurRduhfVQtgCsx4oh8tL8EAA7F9KzTLFnW51UagIAPZtK1VV6cisdBmdCo9PCQCNgsfrCrP3OIQ_s7xnm_xiq4wztqSUafBxpMhRK9Ztk=" rel="nofollow" target="_blank" rel="nofollow"><u>Wolf Haldenstein Adler Freeman &amp; Herz LLP </u></a> announces that a federal class action securities lawsuit has been filed in the United States District Court for Northern District of Texas on behalf of purchasers of the securities of Match Group, Inc. ("Match") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ" rel="nofollow">MTCH</a>) from August 6, 2019 through September 25, 2019, inclusive (the "Class Period). <br /></p> <p align="justify"><strong>Investors who purchased shares </strong><strong>of Match Group, Inc.</strong> <strong>are u</strong><strong>rged</strong><strong> to contact the firm immediately at <a href="https://www.globenewswire.com/Tracker?data=nkrkPniwQ4wcStQuGyjl16XpZMKxvaUftpAiOizIy60sen2pGCLG3t-DDfq5h0oj3bTVWpLqwrsYhfEjWzHdKqkdx-5JKQPKRPWtwBfiRoE=" rel="nofollow" target="_blank" rel="nofollow"><u>classmember@whafh.com</u></a> or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action on our website, <a href="https://www.globenewswire.com/Tracker?data=M1I5cMEun0iA0sADIIFGn9kKCtrg6cHcbhfCbVR92HkXEnZNADsRfNJCkcIaIwbRDERnB1zC5vRPggcVDy9rNyKkZfvMrFq6DgrS1U-gZQH1TtIbI9cLcH7x3NJ0S3le" rel="nofollow" target="_blank" rel="nofollow">www.whafh.com.</a></strong></p> <p align="justify">If you have incurred losses in the shares of <strong>Match Group, Inc., y</strong><strong>ou may,</strong> <strong>no later than December 2, 2019</strong><strong>, </strong>request that the Court ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14640093/match-group-inc-investor-alert-wolf-haldenstein-adler-freeman-herz-llp-announces-that-a-securities alt=MATCH GROUP, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a securities class action lawsuit has been filed in the United States District for the Northern District of Texas on behalf of purchasers of the securities of Match Group, Inc.>Full story available on Benzinga.com</a></p> MTCH News Legal Press Releases MTCH News Legal Press Releases Benzinga Tue, 22 Oct 2019 20:15:05 +0000 Globe Newswire 14640093 at https://www.benzinga.com SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SciPlay Corporation - SCPL https://www.benzinga.com/pressreleases/19/10/g14639554/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-sciplay-corpora <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="left">NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SciPlay Corporation ("SciPlay" or the "Company") (NASDAQ: SCPL).   Such investors are advised to contact Robert S. Willoughby at <a href="https://www.globenewswire.com/Tracker?data=tnigsUgM-wUnt5MgB72F5hhaTMjOPdN_ulc3o88CwQG4rvAZwnrazym5lg82iyaPh1gFlAIBq0awA8B6UTYQBmfY8rWJa18vfzwEwdBm8zE=" rel="nofollow" target="_blank" rel="nofollow">rswilloughby@pomlaw.com</a> or 888-476-6529, ext. 9980.<br /></p> <p align="justify">The investigation concerns whether SciPlay and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. </p> <p align="center"><a href="https://www.globenewswire.com/Tracker?data=sh9SmcVoWo00D0JI9jn6G_Kx8eOq66lYiGQYAfn1oQMnGZBEWneOj4b0bRSIbyR_R-fPDMeWjV2KZ6Lw2LbqoEwkS_oQ0L-pi9b0KdjKnFNuO5Wnape1sfRAc20q_oI57aCN4k-VDzKn3z_v6iSFQ5yuofHld4S7RVd2cPQs0M0=" rel="nofollow" target="_blank" rel="nofollow"><strong>[Click here for information ...</strong></a></p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14639554/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-sciplay-corpora alt=SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SciPlay Corporation - SCPL>Full story available on Benzinga.com</a></p> News Legal Press Releases News Legal Press Releases Benzinga Tue, 22 Oct 2019 19:32:28 +0000 Globe Newswire 14639554 at https://www.benzinga.com Merger Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – DOVA, VSI, PRTO https://www.benzinga.com/pressreleases/19/10/g14639413/merger-investigation-alert-halper-sadeh-llp-continues-to-investigate-whether-the-sale-of-these-com <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="justify">NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:<br /></p> <p align="justify"><strong>Dova Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOVA#NASDAQ" rel="nofollow">DOVA</a>)<br /></strong>The investigation concerns whether Dova and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Dova to Swedish Orphan Biovitrum AB. Under the terms of the agreement, Dova shareholders will be offered an upfront payment for $27.50 per share in cash and one non-tradeable Contingent Value Right to an additional $1.50 per share in cash upon regulatory approval of DOPTELET. If you are a Dova shareholder and would like to learn more about your legal rights and options, please visit: <a ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14639413/merger-investigation-alert-halper-sadeh-llp-continues-to-investigate-whether-the-sale-of-these-com alt=Merger Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – DOVA, VSI, PRTO>Full story available on Benzinga.com</a></p> DOVA News PRTO VSI Legal Press Releases VSI US92849E1010 PRTO DOVA News Legal Press Releases Benzinga Tue, 22 Oct 2019 19:11:19 +0000 Globe Newswire 14639413 at https://www.benzinga.com Merger Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – IPHS, ACHN, RARX, TSG https://www.benzinga.com/pressreleases/19/10/g14639381/merger-investigation-alert-halper-sadeh-llp-continues-to-investigate-whether-the-sale-of-these-com <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="justify">NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:<br /></p> <p align="justify"><strong>Innophos Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPHS#NASDAQ" rel="nofollow">IPHS</a>)</strong></p> <p align="justify">The investigation concerns whether Innophos and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Innophos to an affiliate of One Rock Capital Partners, LLC for $32.00 per share. If you are an Innophos shareholder and would like to learn more about your legal rights and options, please visit: <a href="https://www.globenewswire.com/Tracker?data=TgH5SGr-G_KDEGTahXGedfZZWp9iJRsM0q9tDQ92oqXrO9PpvBCpG40Y53ONzoR70TQ66m80SHl-HozQKCkNVsI4ZlBCJLfHqY3GlOT_lPJQXs4ld64UILLaHnb8IxTDTGf50yIowIO98PLeDdB-tZV3DRCIsLmE02YAy6RSJN28Kx2tjx92k-W5_C3Vez4OxCuBPglXtTNJHCe65XYtpLqml0t9KuVrisEtHG_VlPH9nx60D3NVXkDRBOC4bm7U" rel="nofollow" target="_blank" rel="nofollow"><u>https://halpersadeh.com/actions/innophos-holdings-inc-iphs-stock-merger-one-rock/</u></a>.</p> <p align="justify"><strong>Achillion Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHN#NASDAQ" rel="nofollow">ACHN</a>) </strong></p> <p align="justify">The investigation concerns whether Achillion and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Achillion to Alexion Pharmaceuticals, Inc. ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14639381/merger-investigation-alert-halper-sadeh-llp-continues-to-investigate-whether-the-sale-of-these-com alt=Merger Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – IPHS, ACHN, RARX, TSG>Full story available on Benzinga.com</a></p> ACHN IPHS News RARX TSG Legal Press Releases ACHN US00448Q2012 IPHS US45774N1081 TSG RARX News Legal Press Releases Benzinga Tue, 22 Oct 2019 19:07:00 +0000 Globe Newswire 14639381 at https://www.benzinga.com INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in MTCH, CADE, and OLLI of Filing Deadlines https://www.benzinga.com/pressreleases/19/10/g14639242/investor-class-action-deadlines-bernstein-liebhard-llp-reminds-investors-in-mtch-cade-and-olli-of- <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that class action complaints have been filed on behalf of shareholders of MTCH, CADE, and OLLI. If you wish to serve as lead plaintiff, you must move the court by the lead plaintiff deadlines listed below. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn&#039;t require that you serve as lead plaintiff. If you take no action, you may remain an absent class member. <br /></p> <p>To discuss the cases below please contact <a href="https://www.globenewswire.com/Tracker?data=ZonXj6D6lBw49nr8nsyD9XVvCozDxHklv4N-9euBc2a7IBX5Ve_mqiwE6IZMPl_D5slFP_ArwUemdxLrJ9dyG7Ntz0hvE17mzFm0BHEJBs8=" rel="nofollow" target="_blank" rel="nofollow"><u>Matthew E. Guarnero</u></a> toll free at (877) 779-1414.</p> <p><strong>Match Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ" rel="nofollow">MTCH</a>)<br /> CLASS PERIOD: </strong>08/06/2019 - 09/25/2019<strong><br /> LEAD PLAINTIFF DEADLINE:</strong> December 2, 2019</p> <p>Throughout the Class Period, Defendants made material misstatements and/or failed to disclose that: (i) that the Company used fake love interest ads to convince customers to buy and upgrade subscriptions; (ii) that the Company made it difficult and confusing for consumers to cancel their subscriptions; (iii) that, as a result, the Company was reasonably likely to be subject to regulatory scrutiny; (iv) that the Company lacked adequate disclosure controls and procedures; and (v) ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14639242/investor-class-action-deadlines-bernstein-liebhard-llp-reminds-investors-in-mtch-cade-and-olli-of- alt=INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in MTCH, CADE, and OLLI of Filing Deadlines>Full story available on Benzinga.com</a></p> CADE MTCH News OLLI Legal Press Releases CADE MTCH OLLI News Legal Press Releases Benzinga Tue, 22 Oct 2019 18:49:11 +0000 Globe Newswire 14639242 at https://www.benzinga.com INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in SONM, UBER, and COF of Filing Deadlines https://www.benzinga.com/pressreleases/19/10/g14639199/investor-class-action-deadlines-bernstein-liebhard-llp-reminds-investors-in-sonm-uber-and-cof-of-f <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that class action complaints have been filed on behalf of shareholders of SONM, UBER, and COF. If you wish to serve as lead plaintiff, you must move the court by the lead plaintiff deadlines listed below. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn&#039;t require that you serve as lead plaintiff. If you take no action, you may remain an absent class member. <br /></p> <p>To discuss the cases below please contact <a href="https://www.globenewswire.com/Tracker?data=OakRxWWO5m9bCtIoMjNIHp2Q82C1jG3Fu4Ko7REoZaGmEOSbykqaaq17MV7R56beEp2ST5PzQIMCyNdPmqnQfSSU13tscxYRCKjUYQCIcHk=" rel="nofollow" target="_blank" rel="nofollow"><u>Matthew E. Guarnero</u></a> toll free at (877) 779-1414.</p> <p><strong>Sonim Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONM#NASDAQ" rel="nofollow">SONM</a>)</strong><br /> <strong>LEAD PLAINTIFF DEADLINE: </strong>December 6, 2019</p> <p>Defendants failed to disclose to investors: Specifically, Defendants failed to disclose to investors: (1) that the Company&#39;s XP8 was experiencing material software challenges; (2) that these software issues adversely affected how the device&#39;s Qualcomm chipset, which supported Band 14 access, connected to AT&amp;T&#39;s carrier network configuration; (3) that the Company&#39;s XP5 and XP3 devices were experiencing material software defects that adversely affected their optimization with certain accessories; (4) that, as a result, the Company was reasonably likely to delay the launch of new ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14639199/investor-class-action-deadlines-bernstein-liebhard-llp-reminds-investors-in-sonm-uber-and-cof-of-f alt=INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in SONM, UBER, and COF of Filing Deadlines>Full story available on Benzinga.com</a></p> COF News SONM UBER Legal Press Releases COF US14040H1059 UBER SONM News Legal Press Releases Benzinga Tue, 22 Oct 2019 18:42:40 +0000 Globe Newswire 14639199 at https://www.benzinga.com INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in ECOR, CVET, and DBX of Filing Deadlines https://www.benzinga.com/pressreleases/19/10/g14639160/investor-class-action-deadlines-bernstein-liebhard-llp-reminds-investors-in-ecor-cvet-and-dbx-of-f <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that class action complaints have been filed on behalf of shareholders of ECOR, CVET, and DBX. If you wish to serve as lead plaintiff, you must move the court by the lead plaintiff deadlines listed below. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn&#039;t require that you serve as lead plaintiff. If you take no action, you may remain an absent class member. <br /></p> <p>To discuss the cases below please contact <a href="https://www.globenewswire.com/Tracker?data=NpwvRhyADeFyMw5K4qDTHRMAtE2wJJ5GuX6Qh8Oo0gZUYs7cpVrRUZmUWPm6S7CEAOv9Nzs19JKoeYHzqeisGLaMKuWmC9rhyJF_UFswmLs=" rel="nofollow" target="_blank" rel="nofollow"><u>Matthew E. Guarnero</u></a> toll free at (877) 779-1414.</p> <p><strong>electroCore (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECOR#NASDAQ" rel="nofollow">ECOR</a>)<br /> CLASS PERIOD: </strong>06/19/2018-09/25/2019<br /> <strong>LEAD PLAINTIFF DEADLINE: </strong>November 25, 2019</p> <p>Defendants made false and/or misleading statements and/or failed to disclose to investors: (i) that the Company&#039;s lead product, gammaCore, did not enjoy any advantages over other acute treatments for migraines and episodic cluster headaches; (ii) that, as a result, doctors and patients were unlikely to adopt gammaCore over existing treatments; (iii) that the Company&#039;s voucher program was not effective to increase adoption of gammaCore; (iv) that the Company lacked sufficient resources to successfully commercialize gammaCore; (v) that the Company&#039;s business plan and strategy was not sustainable because electroCore lacked sufficient revenue to be profitable; (vi) that the Company&#039;s product registry and efforts were ineffective to initiate reimbursement policies by commercial ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14639160/investor-class-action-deadlines-bernstein-liebhard-llp-reminds-investors-in-ecor-cvet-and-dbx-of-f alt=INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in ECOR, CVET, and DBX of Filing Deadlines>Full story available on Benzinga.com</a></p> CVET DBX ECOR News Legal Press Releases DBX ECOR CVET News Legal Press Releases Benzinga Tue, 22 Oct 2019 18:38:55 +0000 Globe Newswire 14639160 at https://www.benzinga.com INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in MYGN, TME, and OSTK of Filing Deadlines https://www.benzinga.com/pressreleases/19/10/g14639131/investor-class-action-deadlines-bernstein-liebhard-llp-reminds-investors-in-mygn-tme-and-ostk-of-f <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that class action complaints have been filed on behalf of shareholders of MYGN, TME, and OSTK. If you wish to serve as lead plaintiff, you must move the court by the lead plaintiff deadlines listed below. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn&#039;t require that you serve as lead plaintiff. If you take no action, you may remain an absent class member. <br /></p> <p>To discuss the cases below please contact <a href="https://www.globenewswire.com/Tracker?data=Wvu-PBypqy7xXl-pz-vY462kWiGL_q5L3bVVwP7e2c56-u5H_FzPkrhNvzGsAFnvyHe7rn_neJ8aEXeuyTztr9Cy05EuDwHZI1IWEY1_Rx0=" rel="nofollow" target="_blank" rel="nofollow"><u>Matthew E. Guarnero</u></a> toll free at (877) 779-1414.</p> <p><strong>Myriad Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ" rel="nofollow">MYGN</a>)<br /> CLASS PERIOD: </strong>09/2/2016-08/13/2019<br /> <strong>LEAD PLAINTIFF DEADLINE: </strong>November 26, 2019</p> <p>Defendants made false and/or misleading statements and/or failed to disclose that: (i) GeneSight lacked evidence or information sufficient to support the tests in their current form, including their purported benefits; (ii) the U.S. Food and Drug Administration (FDA) had requested changes to GeneSight and questioned the validity of the tests purported benefits; (iii) Myriad had been in ongoing discussions with the FDA regarding the FDA&#039;s requested changes to GeneSight; (iv) Myriad&#039;s acquisition of Counsyl and thereby, Foresight caused the Company to incur the risk of suffering ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14639131/investor-class-action-deadlines-bernstein-liebhard-llp-reminds-investors-in-mygn-tme-and-ostk-of-f alt=INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in MYGN, TME, and OSTK of Filing Deadlines>Full story available on Benzinga.com</a></p> MYGN News OSTK TME Legal Press Releases MYGN US62855J1043 OSTK US6903701018 TME News Legal Press Releases Benzinga Tue, 22 Oct 2019 18:35:40 +0000 Globe Newswire 14639131 at https://www.benzinga.com